Analysis of the molecular landscape that characterises a patient or disease is an evolving area that is increasingly driving discoveries in healthcare.
Prime, the founding agency of our group, is renowned for scientific excellence, strategic acumen, innovation, and benchmark-setting medical communication solutions. This is evidenced by the deep and long-standing relationships Prime has nurtured with its numerous pharma and biotech clients; many of which span over 20 years.
Prime’s dedication to providing consistently outstanding quality and working in genuinely close partnership with clients, is the DNA that runs through all agencies within the Prime Global group. With offices around the world, Prime provides a full spectrum of medical communication and educational services.
Mantra.
Be proactive, be responsive
Recent Highlights.
Franchise multi-channel communications strategy and plan, development and implementation.
Another highly successful* interactive satellite symposium just delivered
(*‘excellent symposium’ and ‘excellent work’ according to our client and faculty).
Clients asking us to expand our support, from a single discrete project, to support them across all their medical communication and educational activities in 2017.
Vacancies.
We’re always looking for brilliant people to join our teams! Click the link to find out more about becoming part of Prime Global, view available roles, and apply.
Interesting Challenges.
How do we improve upon an already highly successful (~95% positive feedback) and established annual educational event?
This was precisely the challenge we set ourselves. The solution was to evolve the live event into an ongoing, faculty-led, multi-channel educational curriculum that provided opportunity for enhanced engagement.
Random Fact.
Prime started life in December 1997, on the old grounds of
Barrowmore Hospital near Chester, England.
Barrowmore Hospital, which was founded in 1920, originally specialised in tuberculosis. It later became a centre specialising in helping people with disabilities, before being
adopted into the National Health Service in 1948.
Everything we do is ultimately about ensuring patients receive the best possible medicines and care, so we think it’s very appropriate that our own journey
started where it did.
News.
-
Evolving applications of omics in healthcare
Prime Global 25 May, 2022Evolving applications of omics in healthcareread more >> -
Haemophilia awareness: building trusted relationships between patients and industry
Prime Global 19 April, 2022Haemophilia awareness: building trusted relationships between patients and industryread more >>Haemophilia is a lifelong genetic disorder characterised by excessive bleeding.(1) Despite the existence of treatments for haemophilia, the condition continues to have major impacts on quality of life, for example in the areas of pain (acute and chronic), joint mobility, and physical function.(1) To mark World Haemophilia Day on 17 April, Prime Patient partnered with sister agency HCD Economics, a consultancy specialising in haemophilia patient research, and haemophilia advocate Laurence Woollard to better understand the existing relationship between patients and industry and how meaningful improvements can be made to the lives of people living with haemophilia (PwH).
-
What do developmental disability advocates want Pharma to know?read more >>Prime Patient team up with Jess Duggan from the SynGAP Research Fund to better understand what this advocacy group wants Pharma to know this Developmental Disabilities Awareness Month.
“Action without vision is only passing time, vision without action is merely daydreaming, but vision with action can change the world.”
Nelson Mandela
Get in touch.
We’re always happy to hear from you
Use the contact form or get full details for each of our offices around the world.
Contact us